Although intended by Eli Lilly to be used as a nasal decongestant, Geranamine has been marketed by certain companies as a dietary supplement in combination with caffeine and other ingredients, under trade names such as Geranamine and Floradrene, to be used as an OTC thermogenic or general purpose stimulant. Geranamine itself has not been researched intensively, with its pharmacological profile not looked at since Eli Lilly filed its patent in 1944, stating that the stimulant effects on the CNS are less than that of amphetamine or ephedrine. Geranamine is not FDA approved in its own right, although it is a component of geranium oil which is approved for use in foods, and so this has been used to justify claims that it should be classified as a dietary supplement rather than a pharmaceutical product. However while it may be technically correct to say that geranamine is a dietary supplement as it is a component of the oil from Pelargonium graveolens which is approved for use in foods, geranamine comprises only 0.66% of geranium oil,[5] and pure synthetic geranamine is thus quite different from geranium oil. Synthetic geranamine is used as the active ingredient of several legal party pills.Serious adverse events including headache, nausea, and stroke have been reported in recreational users of these products.These users are suspected to have injected the compound and at doses that exceed safe usage which is why the Health Ministry of New Zealand has not moved to restrict or ban the ingredient. A Health Ministry report to the Government's expert drug committee responsible for classifying drugs said while the hospital admissions were believed to be due to Geranamine use, there was not enough evidence to ban the substance.